Company: BNBX
Filing Date: 2025-02-13
Form Type: 10-Q
Source: 0001410578-25-000126
Chunk: 3

Company: BNB PLUS CORP.
Filing Date: 2025-02-13
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
​​​Applied DNA Sciences, Inc. stockholders’ equity:​   ​   Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2024 and September 30, 2024​  —​  —Series A Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of December 31, 2024 and September 30, 2024​  —​  —Series B Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of December 31, 2024 and September 30, 2024​  —​  —​​​ ​​​​Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2024 and September 30, 2024,  54,111,523 and 10,311,885 shares issued and outstanding as of December 31, 2024 and September 30, 2024, respectively​  54,114​  10,314Additional paid in capital ​  339,918,754​  318,805,058Accumulated deficit ​  (327,219,390)​  (309,672,755)Applied DNA Sciences, Inc. stockholders’ equity​  12,753,478​  9,142,617Noncontrolling interest​​ (203,833)​​ (174,532)Total equity​​ 12,549,645​​ 8,968,085 ​​​​​​​Total liabilities and equity​$ 15,970,701​$ 12,789,040

​

See the accompanying notes to the unaudited condensed consolidated financial statements

​